Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-23T00:37:22.620Z Has data issue: false hasContentIssue false

Alternative uses of the Rashkind umbrella device in congenital and post-surgical cardiovascular lesions—early results and impact on clinical course

Published online by Cambridge University Press:  19 August 2008

Hussein Tabatabaei
Affiliation:
From the Departments of Pediatrics and Surgery, Divisions of Cardiology and Cardiovascular Surgery, The Variety Club Cardiac Catheterization Laboratories, The Hospital for Sick Children, University of Toronto, School of Medicine, Toronto
David G. Nykanen
Affiliation:
From the Departments of Pediatrics and Surgery, Divisions of Cardiology and Cardiovascular Surgery, The Variety Club Cardiac Catheterization Laboratories, The Hospital for Sick Children, University of Toronto, School of Medicine, Toronto
William G. Williams
Affiliation:
From the Departments of Pediatrics and Surgery, Divisions of Cardiology and Cardiovascular Surgery, The Variety Club Cardiac Catheterization Laboratories, The Hospital for Sick Children, University of Toronto, School of Medicine, Toronto
Robert M. Freedom
Affiliation:
From the Departments of Pediatrics and Surgery, Divisions of Cardiology and Cardiovascular Surgery, The Variety Club Cardiac Catheterization Laboratories, The Hospital for Sick Children, University of Toronto, School of Medicine, Toronto
Lee N. Benson*
Affiliation:
From the Departments of Pediatrics and Surgery, Divisions of Cardiology and Cardiovascular Surgery, The Variety Club Cardiac Catheterization Laboratories, The Hospital for Sick Children, University of Toronto, School of Medicine, Toronto
*
Dr. Lee N. Benson, The Hospital For Sick Children, 555 University Avenue, Toronto Ontario, Canada, M5G 1X8. Tel. 416 8136141; Fax. 4168137547.

Summary

Implantation of the Rashkind double umbrella device for closure of the persistently patent arterial duct is now routine in many units. The use of this device in non-ductal positions, however, has been reported in only a limited number of patients, and its impact on the subsequent clinical course has not been established. A retrospective review of all such occlusions, therefore, was undertaken to address the early results and impact on clinical management. From 9/1988 through 2/1994, implantation of a double umbrella device was attempted in 21 patients (eight female, 13 male) with cardiovascular communications other than a persistent arterial duct excluding the intentional fenestrations made in the modified Fontan procedure. Median age at implantation was 2.6 years (three months-12.4 years) and weight was 11.6 kg (4.1–45) kg. Lesions included four ventricular septal defects, an aortopulmonary window, an aortopulmonary collateral artery, an atrial septal defect, four Gore-tex® shunts, and a residual persistent communication between the superior caval vein and the right atrium following either a bidirectional cavopulmonary anastomosis, or a classical Glenn operation. Eight patients underwent occlusion of unintentional residual right-to-left (six) or left-to-right (two) communications following the Fontan procedure. Implantation was accomplished in all without mortality, utilizing either 12 mm (13) or 17 mm (eight) devices. Surgical removal of the device was required in one patient four weeks subsequent to implantation. At latest follow-up (1–66 months, median four months), color-flow Doppler studies revealed complete occlusion in 17 (77%) patients. Implantation of the double umbrella in sites other than the duct is, therefore, feasible and simplified technically with a modification of the delivery system. Such novel applications of transcatheter intervention using double umbrella devices may avoid or complement subsequent surgery.

Type
Original Manuscripts
Copyright
Copyright © Cambridge University Press 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Rashkind, WJ, Cuaso, CC. Transcatheter closure of patent ductus arteriosus: Successful use in a 3.5 kilogram infant. Pediatr Cardiol 1979; 1:37.CrossRefGoogle Scholar
2.Rashkind, WJ, Mullins, CE, Hellenbrand, WE, Tait, MA. Nonsurgical closure of patent ductus arteriosus: clinical application of the Rashkind PDA occluder system. Circulation 1987; 75: 583592.CrossRefGoogle ScholarPubMed
3.Benson, LN. Catheter closure of the ductus arteriosus. In: Rao, PS (ed). Transcatheter Therapy in Pediatric Cardiology. Wiley-Liss, Inc., New York, 1993, pp 321333.Google Scholar
4.Wessel, DL, Keane, JF, Parness, I, Lock, JE. Outpatient closure of pa tent ductus arteriosus. Circulation 1988;77: 10681671.CrossRefGoogle Scholar
5.Dyck, JD, Benson, LN, Smallhorn, JF, McLaughlin, PR. Freedom, RM, Rowe, RD. Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol 1988; 62: 10891092.CrossRefGoogle ScholarPubMed
6.Mullins, CE. Pediatric and congenital therapeutic cardiac catheterization. Circulation 1989; 79: 11531159.CrossRefGoogle ScholarPubMed
7.Musewe, NN, Benson, LN, Smallhorn, JF, Freedom, RM. Two dimensional echocardiographic and color-flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis. Circulation 1989; 80: 17061710.CrossRefGoogle ScholarPubMed
8.Hosking, MCK, Benson, LN, Musewe, NN, Dyck, JD, Freedom, RM. Transcatheter occlusion of persistently patent ductus arteriosus. Forty month follow-up and prevalence of residual shunting. Circulation 1991; 84: 23132317.CrossRefGoogle ScholarPubMed
9.Tynan, M. Transcatheter occlusion of persistent arterial duct. Report of the European registry. Lancet 1992; 340: 10621066.Google Scholar
10.Ali Khan, MA, Al, YousefS, Mullins, CE, Sawyer, W. Experience with 205 procedures of transcatheter closure of the ductus arteriosus in 182 patients with special reference to residual shunts and long-term follow-up. J Thorac Cardiovasc Surg 1992; 104: 17211727.CrossRefGoogle ScholarPubMed
11.Lock, JE, Cokerham, JT, Keane, JF, Finley, JP, Wakely, PE Jr, Fellows, KE. Transcatheter umbrella closure of congenital heart defects. Circulation 1987; 75: 593599.CrossRefGoogle ScholarPubMed
12.Hellenbrand, WE, Mullins, CE. Catheter closure of congenital cardiac defects. Cardiol Clinics 1989; 7: 351368.CrossRefGoogle ScholarPubMed
13.Perry, SB, Lock, JE. Front loading of the double umbrella device, a new technique for umbrella delivery for closing cardiovascular defects. Am J Cardiol 1992; 70: 917920.CrossRefGoogle ScholarPubMed
14.Houde, C, Zahn, EM, Benson, LN. Transcatheter closure of BlaJock Taussig shunts with a modified Rashkind umbrella delivery system. Br Heart J 1993; 69: 5658.CrossRefGoogle ScholarPubMed
15.Redington, AN, Rigby, ML. Novel uses of the Rashkind ductal umbrella in adults and children with congenital heart disease. Br Heart J 1993; 69: 4751.CrossRefGoogle ScholarPubMed
16.Cullen, S, Somerville, J, Redington, A. Transcatheter closure of a ruptured aneurysm of the sinus of Valsalva. Br Heart J 1994; 71:479480.CrossRefGoogle ScholarPubMed
17.Hayes, AM, Burrows, PE, Benson, LN. An unusual cause of cyanosis after the modified Fontan procedure—closure of venous communications between the coronary sinus and left atrium by transcatheter techniques. Cardiol Young 1994; 4: 172174.CrossRefGoogle Scholar
18.Nykanen, DG, Hays, AM, Benson, LN, Freedom, RM. Transcatheter patent ductus arteriosus occlusion: application in the small child. J Am Coll Cardiol 1994; 23: 16661670.CrossRefGoogle ScholarPubMed
19.Redington, AN, Rigby, ML. Transcatheter closure of interatrial communications with a modified umbrella device. Br Heart J 1994; 72: 372377.CrossRefGoogle ScholarPubMed
20.Rigby, ML, Redington, AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br Heart J 1994:72:368371.CrossRefGoogle ScholarPubMed
21.Wallace, S, Gianturo, C, Anderson, JH, Goldstein, HM, Davis, LJ, Bree, RL. Therapeutic vascular occlusion utilizing steel coil technique: clinical applications. Am J Roentgenol 1976; 127: 381387.CrossRefGoogle ScholarPubMed
22.Huggon, IC, Tabatabaei, H, Qureshi, SA, Baker, EJ, Tynan, M. Use of a second transcatheter Rashkind arterial duct occluder for persistent flow after implantation of the first device: indications and results. Br Heart J 1993; 69: 544550.CrossRefGoogle Scholar
23.Nykanen, DG, Perry, SB, Keane, JF, Moore, P, Lock, JE. Transcatheter occlusion of ventricular septal defects: Experience in 80 patients with congenital heart disease. Circulation 1993: 88(Suppl I): 1532. [Abstract]Google Scholar
24.Serraf, A, Lacour-Gayet, F, Bruniaux, J, Ouaknine, R, Losay, J,Binet, J, Planché, C. Surgical management of isolated multiple ventricular septal defects. J Thorac Cardiovasc Surg 1992; 103: 437443.CrossRefGoogle ScholarPubMed
25.Rizzoli, G, Blackstone, EH, Kirklin, JW, Pacifico, AD, Bargeron, LM Jr. Incremental risk factors in hospital mortality after repair of ventricular septal defect. J Thorac Cardiovasc Surg 1980;80:494505.CrossRefGoogle ScholarPubMed
26.Fontan, F, Kirklin, JW, Fernández, G, Costa, F, Naftel, D, Tritto, F, Blackstone, EH. Outcome after a perfect Fontan operation. Circulation 1990; 81: 15201536.CrossRefGoogle ScholarPubMed
27.Parikh, SR, Hurwitz, RA, Caldwell, RL, Girod, DA. Ventricular function in the single ventricle before and after Fontan surgery. Am J Cardiol 1988; 67: 13901395.Google Scholar
28.Graham, TP, Franklin, RCG, Wyse, RKH, Ghooch, V, Deanfield, JE. Left ventricular wall stress and contractile function in childhood: normal values and comparison of Fontan repair versus palliation only in patients with tricuspid atresia. Circulation 1986; 74(Suppl I): I61.Google ScholarPubMed
29.Bridges, ND, Lock, JE, Castaneda, AR. Baffle fenestration with subsequent transcatheter closure, modification of the Fontan operation for patients at increased risk. Circulation 1990; 82: 16811689.CrossRefGoogle ScholarPubMed